Cellebrite Reports 19% Revenue Growth and 21% ARR Rise While Price Target Hits $15
Cellebrite DI Ltd. reported Q1 2026 revenue of $128.3 million, up 19% year-over-year, and earned $0.12 per share, surpassing estimates. Annual recurring revenue rose 21% to $493 million and adjusted EBITDA increased 29% to $30.6 million while Needham set a $15.00 price target implying a 15.12% upside.
1. Analyst Price Target Adjustment
Needham reduced its price target for Cellebrite DI Ltd. to $15.00 from $18.00, implying a 15.12% upside based on the stock’s prevailing trading level. This adjustment reflects continued analyst confidence despite a more conservative valuation outlook.
2. Q1 Revenue and Earnings Beats
In the first quarter of 2026, Cellebrite DI Ltd. generated $128.3 million in revenue, marking a 19% increase year-over-year. The company delivered earnings of $0.12 per share, exceeding the prior consensus estimate of $0.11.
3. ARR and EBITDA Growth
Annual recurring revenue climbed 21% to $493 million, driven by a 23% surge in subscription revenue. Adjusted EBITDA rose 29% to $30.6 million, underlining strong operational leverage in the digital intelligence segment.
4. Future Growth Drivers
Management highlighted robust customer uptake of new AI, cloud management and drone forensics offerings. The company expects these innovations to accelerate ARR expansion in upcoming quarters.